Please provide your email address to receive an email when new articles are posted on . A majority of patients with age-related macular degeneration treated with investigational gene therapy GT005 ...
Researchers from Children's Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ultra-rare genetic disorder that can cause ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results